• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Mithramycin

Mithramycin

Product ID M3476
Cas No. 18378-89-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $84.50 In stock
5 mg $338.00 In stock
10 mg $619.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Mithramycin is an aureolic acid-type polyketide antibiotic initially produced by species of Streptomyces. Mithramycin exhibits neuroprotective and anticancer chemotherapeutic activities. In animal models of Huntington’s disease, mithramycin prevented increases in H3 histone methylation, delaying disease pathology, improving motor performance, and increasing survival rates. Mithramycin is a reversible inhibitor of RNA synthesis, binding CG and GC sequences and inhibiting transcription initiation. Mithramycin also inhibits CpG methylation of tumor-suppressor genes through direct inhibition of DNA methyltransferase 1 (DNMT1) activity in lung cancer cells. In cellular and animal models of prostate cancer, mithramycin increases levels of tBid and decreases levels of mTOR and Mcl-1, inducing apoptosis and inhibiting tumor growth.

Product Info

Cas No.

18378-89-7

Purity

≥98%

Formula

C52H76O25

Formula Wt.

1084.47

IUPAC Name

(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4-[(2S,4S,5R,6R)-4, 5-dihydroxy-4, 6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6- methyloxan-2-yl]oxy-3-[(1S,3S,4R)-3, 4-dihydroxy-1-methoxy-2-oxopentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4, 5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8, 9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one InChI: InChI=1S/C52H76O24/c1-18-29(72-34-14-30(43(58)21(4)68-34)73-33-13-28(54) 42(57)20(3)67-33)12-26-10-25-11-27(49(66-9)48(63)41(56)19(2)53)50(47(62) 39(25)46(61)38(26)40(18)55)76-36-16-31(44(59)23(6)70-36)74-35-15-32(45 (60)22(5)69-35)75-37-17-52(8,65)51(64)24(7)71-37/h10,12,19-24,27-28, 30-37,41-45,49-51,53-61,64-65H,11,13-17H2,1-9H3/t19-,20-,21-,22-,23-, 24-,27+,28-,30-,31-,32-,33+,34+,35+,36+,37+,41+,42-,43-,44-,45+,49+,50+, 51-,52+/m1/s1

Synonym

Plicamycin, Mithramycin A

Melting Point

175-180°C

Solubility

DMSO (20 mg/ml), Methanol, Ethanol (10 mg/ml)

Appearance

Yellow Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

M3476 MSDS PDF

Info Sheet

M3476 Info Sheet PDF

Brochures

Epigenetic Modifiers Booklet

References

Choi ES, Chung T, Kim JS, et al. Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells. J Clin Biochem Nutr. 2013 Sep;53(2):89-93. PMID: 24062605.

Choi ES, Jung JY, Lee JS, et al. Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model. Cancer Lett. 2013 Jan 1;328(1):65-72. PMID: 23000424.

Lin RK, Hsu CH, Wang YC. Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells. Anticancer Drugs. 2007 Nov;18(10):1157-64. PMID: 17893516.

Ferrante RJ, Ryu H, Kubilus JK, et al. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J Neurosci. 2004 Nov 17;24(46):10335-42. PMID: 15548647.

Miller DM, Polansky DA, Thomas SD, et al. Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci. 1987 Nov;294(5):388-94. PMID: 2962490.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F5976

    Fotemustine

    Chloroethylnitrosourea, DNA alkylator and cross...

    ≥98%
  • G3352

    Ginkgolic Acid (13:0)

    Alkylphenol found in Ginkgo; HIV protease inhib...

    ≥98%
  • D3203

    Diallyl Tetrasulfide

    Organosulfur found in garlic; Microtubule polym...

    ≥90%
  • M568264

    Mogroside IIe

    Triterpenoid

    ≥98%
  • L1340

    LDK378

    ALK and IGF-1R inhibitor.

    ≥99%
  • G0247

    2″O-Galloylhyperin

    Flavonoid glycoside found in Pyrola.

    ≥98%
  • O9497

    Oxytocin

    Endogenous neuropeptide hormone, involved in so...

    ≥95%
  • T3096

    Thymosin α-1

    Endogenous peptide fragment, immunostimulant; ...

    ≥95%
  • R3224

    Rigin

    Peptide, IgG derivative, tuftsin analog.

    ≥95%
  • V014463

    Valsartan Methyl Ester

    Valsartan impurity

    ≥98%
  • R0245

    Raltitrexed

    Folate analog; thymidylate synthase inhibitor.<...

    ≥98%
  • A980005

    AZ-5104

    Inhibitor of EGFR.

    ≥98%
  • D3218

    Diethylstilbestrol

    Synthetic non-steroid endocrine disrupter; ER a...

    ≥98%
  • A6979

    Dihydroartemisinin

    Sesquiterpene lactone derived from Artemesia; m...

    ≥96%
  • G7444

    GSK-1070916

    AurKB/C inhibitor.

    ≥98%
  • G7200

    GS-967

    Na+ channel blocker.

    ≥98%
  • D5992

    Doxapram Hydrochloride Hydrate

    K+ channel blocker, catecholamine release stimu...

    ≥98%
  • I5440

    INK128

    mTOR inhibitor.

    ≥99%
  • C1624

    Cefuroxime Sodium

    β-lactam; penicillin binding protein inhibitor...

    ≥98%
  • B3211

    (+)-Bicuculline

    NMDA potentiator, GABA-A antagonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only